IL100162A - Oral pharmaceutical composition containing cyclosporin and its preparation - Google Patents

Oral pharmaceutical composition containing cyclosporin and its preparation

Info

Publication number
IL100162A
IL100162A IL10016291A IL10016291A IL100162A IL 100162 A IL100162 A IL 100162A IL 10016291 A IL10016291 A IL 10016291A IL 10016291 A IL10016291 A IL 10016291A IL 100162 A IL100162 A IL 100162A
Authority
IL
Israel
Prior art keywords
cyclosporin
parts
mass
volume
solutions
Prior art date
Application number
IL10016291A
Other languages
English (en)
Other versions
IL100162A0 (en
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of IL100162A0 publication Critical patent/IL100162A0/xx
Publication of IL100162A publication Critical patent/IL100162A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL10016291A 1990-11-27 1991-11-27 Oral pharmaceutical composition containing cyclosporin and its preparation IL100162A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU907653A HU208491B (en) 1990-11-27 1990-11-27 Process for producing oral pharmaceutical composition containing cyclosporin

Publications (2)

Publication Number Publication Date
IL100162A0 IL100162A0 (en) 1992-08-18
IL100162A true IL100162A (en) 1995-11-27

Family

ID=10972318

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10016291A IL100162A (en) 1990-11-27 1991-11-27 Oral pharmaceutical composition containing cyclosporin and its preparation

Country Status (18)

Country Link
US (1) US5430017A (cs)
EP (1) EP0512109B1 (cs)
JP (1) JPH082795B2 (cs)
AT (1) ATE129898T1 (cs)
AU (1) AU651154B2 (cs)
CA (1) CA2072983A1 (cs)
CS (1) CS230492A3 (cs)
DE (1) DE69114476T2 (cs)
DK (1) DK0512109T3 (cs)
FI (1) FI923385A0 (cs)
HU (1) HU208491B (cs)
IL (1) IL100162A (cs)
MX (1) MX9102243A (cs)
NO (1) NO922961L (cs)
NZ (1) NZ240762A (cs)
PT (1) PT99623A (cs)
WO (1) WO1992009299A1 (cs)
ZA (1) ZA919352B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
ES2177652T3 (es) 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
AU764599B2 (en) * 1995-08-25 2003-08-21 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
MX9702809A (es) * 1995-08-25 1998-02-28 Sangstat Medical Corp Formulaciones orales de ciclosporina.
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
KR20050084502A (ko) 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
KR100966245B1 (ko) * 1997-03-12 2010-06-28 아보트 러보러터리즈 사이클로스포린 투여용 친수성 2원 시스템
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
DK1154759T3 (da) 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290460C (cs) *
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine

Also Published As

Publication number Publication date
EP0512109B1 (en) 1995-11-08
NO922961L (no) 1992-09-23
FI923385A7 (fi) 1992-07-27
US5430017A (en) 1995-07-04
JPH082795B2 (ja) 1996-01-17
AU8944091A (en) 1992-06-25
FI923385L (fi) 1992-07-27
DK0512109T3 (da) 1995-12-11
WO1992009299A1 (en) 1992-06-11
CA2072983A1 (en) 1992-05-28
JPH05503306A (ja) 1993-06-03
AU651154B2 (en) 1994-07-14
HU208491B (en) 1993-11-29
ATE129898T1 (de) 1995-11-15
PT99623A (pt) 1992-12-31
EP0512109A1 (en) 1992-11-11
CS230492A3 (en) 1992-12-16
HUT60929A (en) 1992-11-30
NZ240762A (en) 1993-05-26
NO922961D0 (no) 1992-07-27
ZA919352B (en) 1992-09-30
HU907653D0 (en) 1991-06-28
DE69114476D1 (de) 1995-12-14
DE69114476T2 (de) 1996-04-18
IL100162A0 (en) 1992-08-18
FI923385A0 (fi) 1992-07-27
MX9102243A (es) 1992-07-08

Similar Documents

Publication Publication Date Title
US5430017A (en) Oral pharmaceutical composition containing cyclosporin and process for preparing same
US5047396A (en) Intravenous pharmaceutical composition and process for preparing the same
JP2008120836A (ja) 増大したバイオアベイラビリティーを有する抗真菌組成物
HU215966B (hu) Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
PT93079B (pt) Processo para a preparacao de composicoes farmaceuticas que contem ciclosporinas
JP2012006931A (ja) 疎水性治療剤の改善された送達のための組成物および方法
NO176082B (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
AU616049B2 (en) Etoposide solutions
AU709548B2 (en) Oral cyclosporin formulations
CA2133174A1 (en) Rapamycin formulations for oral administration
WO2008022557A1 (fr) Composition liquide de sirolimus
EP3187172A1 (en) Cyclosporine a topical compositions
Bates et al. Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man
WO2010141068A1 (en) Opthalmic compositions of cyclosporin
EP3930713B1 (en) Stable tacrolimus ointment formulation for topical treatment of skin conditions
EP3758686B1 (en) Pharmaceutical dosage form for an emulsion of simethicone and loperamide
JP2973077B2 (ja) ビタミンｅ製剤組成物
KR100341203B1 (ko) 유성 비타민 함유 약학 조성물 및 이의 제조방법
SK8702001A3 (en) Cyclosporin solution
Whipple et al. Pharmacokinetic evaluation of a new oral cyclosporine formulation
CN118043034A (zh) 克立咪唑制剂
KR20040055669A (ko) 시클로스포린계 약학적 조성물
Etzine, S. & Taylor Inhibition of carbonic anhydrase in the treatment of glaucoma
HK1253053A1 (zh) 含有非索非那丁的软明胶胶囊

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void